Integrated analysis of transcriptomics and metabolomics profiles

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 5, 2008, Pages 497-509

  Cuperlovic Culf, Miroslava ^a   Belacel, Nabil ^a   Culf, Adrian ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b MOUNT ALLISON UNIVERSITY   (Canada)

Author keywords

Classification; Feature analysis; Integromics; Metabolomics; Poly omics; Transcriptomics

Indexed keywords

DNA; PARACETAMOL; RNA;

CANCER CELL; COLON CANCER; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DNA FINGERPRINTING; DNA MICROARRAY; DRUG TARGETING; FATTY LIVER; FUNCTIONAL GENOMICS; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; INFRARED SPECTROSCOPY; LIVER TOXICITY; LUNG CANCER; METABOLITE; METABOLOMICS; MICROARRAY ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; RAMAN SPECTROMETRY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; TRANSCRIPTOMICS;

EID: 77953417367     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.5.497     Document Type: Review

References (98)

1. Hamdan MH. Cancer biomarkers. Hoboken: John Wiley & Sons; 2007
2. De Wit NCJ. Genomics and proteomics in cancer research and diagnosis. In: Pelengaris S, Khan M, editors. The molecular biology of cancer. Blackwell publishing: Malden; 2006
3. Cuperlovic-Culf M, Belacel N, Ouellette RJ. Determination of tumour marker genes from gene expression data. Drug Discov Today 2005;10:429-437 (Pubitemid 40450273)
4. Knudsen S. Cancer diagnostics with DNA microarrays. New Jersey: Wiley; 2006
5. FDA Clears First of Kind Genetic Lab Test. Available from: http://www.fda.gov/bbs/topics/news/2004/new01149.html http://www.agendia.com/ index.php?option=com-content&task=view&id=162&Itemid=239
6. Agendia BV Closes Third Financing Round. Available from: http://www.agendia.com/index.php?option=com-content&task=view&id= 162&Itemid=239
7. Belacel N, Cuperlovic-Culf M, Ouellette RJ. Molecular methods for diagnosis of prostate cancer. US Patent WO2007030919; 2007
8. Oresic M, Vidal-Puig A, Hanninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn 2006;6:575-585 (Pubitemid 44179943)
9. Cox J, Mann M. Is proteomics the new genomics? Cell 2007;130:395-398
10. Serkova NJ, Niemann CU. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn 2006;6:717-731 (Pubitemid 44525597)
11. Pauling LC, Robinson AB, Teranishi R et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA 1971;68:2374-2376
12. Oliver DJ, Nikolau B, Wurtele ES. Functional genomics: high-throughput mRNA, protein and metabolite analysis. Metab Eng 2002;4:98-106 (Pubitemid 34850207)
13. Griffin JL. The Cinderella story of metabolic profiling: does metabolomics get to go the functional genomics ball? Phil Trans R Soc B 2006;361:147-161
14. Weinstein JN. Integromic analysis of the NCI-60 cancer cell lines. Breast Dis 2004;19:11-22 (Pubitemid 39485511)
15. Joyce AR, Palsson BO. The model organism as a system: integrating "omics" data sets. Nat Rev 2006;7:198-210
16. Cox B, Kinslinger T, Emili A. Integrating gene and protein expression data: pattern analysis and profile mining. Methods 2005;35:303-314 (Pubitemid 40255595)
17. Weinstein JN, Pommier Y. Transcriptomic analysis of the NCI-60 cancer cell lines. C R Biol 2003;326:909-992 (Pubitemid 38016446)
18. Kuile BH, Westerhoff HV. Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway. FEBS Lett 2001;500:169-171 (Pubitemid 32607554)
19. Borodina I, Nielsen J. From genomes to in silico cells via metabolic networks. Curr Opin Biotech 2005;16:350-355 (Pubitemid 40806474)
20. Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat Rev 2004;4:551-561 (Pubitemid 38868624)
21. Griffin JL, Blenkiron C, Valonen PK, et al. High-resolution magic angle spinning 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma. Anal Chem 2006;78:1546-1552 (Pubitemid 43346292)
22. Bundy JG, Iyer NG, Gentile MS, et al. Metabolic consequences of p300 gene deletion in human colon cancer cells. Cancer Res 2006;66:7606-7614 (Pubitemid 44289217)
23. Heijne WH, Lamers RAN, Van Bladeren PJ, et al. Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxicol Pathol 2005;33:425-433 (Pubitemid 40995481)
24. Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res 2004;551:51-64 (Pubitemid 38842421)
25. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006;124:758-787 (Pubitemid 44088435)
26. Lorkowski S, Cullen PM. Analyzing gene expression: a handbook of methods possibilities and pitfalls. Weinheim, Germany: Wiley-VCH; 2003
27. Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat Rev 2004;4:551-561 (Pubitemid 38868624)
28. Weckwerth W, editor. Metabolomics: methods and protocols (methods in molecular biology). Totowa, NJ, USA: Humana Press; 2006
29. Lindon JC, Nicholson JK, Holmes E. The handbook of metabonomics and metabolomics. Oxford, UK: Elsevier Science; 2006
30. Kell DB. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today 2006;11:1085-1091 (Pubitemid 44810914)
31. Weckwerth W, Morgenthal K. Metabolomics. from pattern recognition to biological interpretation. Drug Discov Today 2005;10:1551-1618 (Pubitemid 41527198)
32. Beckonert O, Keun HC, Ebbels TMD, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, seruum and tissue extracts. Nat Protocols 2007;2:2692-2702
33. Griffiths WJ, editor. Metabolomics, metabolnomics and metabolite profiling. RSC Publishing: Cambridge UK; 2008
34. Weckwerth W, Wenzel K, Fiehn O. Process for the integrated extraction, identification and quantification of metabolites, proteins and RNA to reveal their co-regulation in biochemical networks. Proteomics 2004;4:78-83 (Pubitemid 38140876)
35. Claudino WM, Quattrone A, Biganzoli L, et al. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol 2007;25:2840-2846 (Pubitemid 47123194)
36. Keun H. Metabonomic modeling of drug toxicity. Pharmacol Ther 2006;109:92-106 (Pubitemid 41740817)
37. Griffing JL, Kauppinen RA. Tumour metabolomics in animal models of human cancer. 2007;6:498-505
38. Brown M, Dunn WB, Ellis DI, et al. A metabolome pipeline: from concept to data to knowledge. Metabolomics 2005;1:39-51 (Pubitemid 40973872)
39. Biljsma S, Bobeldisk I, Verheij ER, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006;78:567-574 (Pubitemid 43100391)
40. Katajamaa M, Oresic M. Data processing for mass spectrometry-based metabolomics. J Chromatogr A 2007;1158:318-328 (Pubitemid 47021150)
41. Shulman RG, Rothman DL, editors. Metabolomics by in vivo NMR. John Wiley & Sons Ltd.: Chichester; 2005
42. Griffin JL, Bonney SA, Mann C, et al. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol Genom 2004;17:140-149 (Pubitemid 38924160)
43. Fan TWM, Bandura LL, Higashi RM, et al. Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics 2005;1:325-339 (Pubitemid 43949748)
44. Ippolito JE, Xu J, Jain S, et al. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci USA 2005;102:9901-9906
45. Urbanczyk-Wochniak E, Luedemann A, Kopka J, et al. Parallel analysis of transcript and metabolic profiles: a new approach in systems biology. ENBO Rep 2003;4:989-993
46. Kanaya S, Kinoushi M, Abe T, et al. Analysis of codon usage diversity for bacterial genes with a self-organizing map (SOM): characterization of horizontally transferred genes with emphasis on the E. coli O157 genome. Gene 2001;276:89-99
47. Hirai MY, Klein M, Fujikawa Y, et al. Elucidation of gene-to-gene and metabolite-to-gene networks in Arabidopsis by integration of metabolomics and transcriptomics. J Biol Chem 2005;280:25590-25595
48. Hirai MY, Yano M, Goodenowe DB, et al. Integration of transcriptomics and metabolomics for understanding of global responses to nutritional stresses in Arabidopsis thaliana, Proc Natl Acad Sci USA 2004;101:10205-10210
49. Pir P, Kirdar B, Hayes A, et al. Integrative investigation of metabolic and transcriptomic data. BMC Bioinf 2006;7:203
50. Oresic M, Clish CB, Davidov EJ, et al. Phenotype characterisation using integrated gene transcript, protein and metabolite profiling. Appl Bioinformatics 2004;3:205-217
51. Van den Maagdenberg AMJM, Hofker MH, Krimpenfort PJA, et al. Transgenic mice carrying the apolipoprotein E3-leiden gene exhibit hyperlipoproteinemia. J Biol Chem 1993;268:10540-10545
52. Scholkopf B, Smola A, Muller KR. Nonlinear component analysis as a kernel eigenvalue problem. Neural Comput 1998;10:1299-1319
53. Ghassemian M, Lutes J, Tepperman JM, et al. Integrative analysis of transcript and metabolite profiling data sets to evaluate the regulation of biochemical pathways during photomorphogenesis. Arch Biochem Biophys 2006;448:45-59
54. Lange BM, Ghassemain M. Comprehensive post-genomic data analysis approaches integrating biochemical pathway maps. Phytochemistry 2005;66:413-451
55. Welcome to the BioPathAt Website. Available from: http://ibc.wsu.edu/ research/lange/pdf/BioPathAt-Mar2005.pdf
56. Coen M, Ruepp SU, Lindon JC, et al. Integrated application of transcriptomics and metabolomics yields. J Pharm Biomed Anal 2004;35:93-105
57. Stegmann A, Hansen M, Wang Y, et al. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNG-4 as a central reguulator of gene expression during enterrocyte differentiation. Physiol Genomics 2006;27:141-155
58. Sonnenburg JL, Chen CTL, Gordon JI. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 2006;4: e413
59. Sonnenburg JL, Xu J, Leip DD, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005;307:1955-1959
60. Castrillo JI, Oliver SG. Yeast as a touchstone in post-genomic research: Strategies for integrative analysis in functional genomics. J Biochem Mol Biol 2004;37:93-106
61. Thomson CE, Ganji G. Integration of genomic and metabonomic data in systems biology-are we there yet? Curr Opin Drug Discov Deve 2006;9:92-100
62. PAM: Prediction Analysis for Microarrays. Available from: www-stat.stanford.edu/-tibs/PAM
63. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Available from: http://gordonlab.wustl.edu/metaview/ippolito/
64. Nicholson JK, Connelly J, Lindon JC, et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153-161
65. Fan TWM, Bandura LL, Higashi RM, Lane AN. Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics 2005;1:325-339
66. Gene Expression Omnibus. Available from: http://www.ncbi.nlm.nih.gov/geo/
67. ArrayExpress. Available from: http://www.ebi.ac.uk/microarray-as/aer/? #ae-main[0]
68. The Metabolomics Society. Available from: http://metabolomicssociety.org/ register/index.php?option=com-frontpage&Itemid=1
69. The HUSERMET project. Available from: http://www.husermet.org/index.php
70. Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis. Chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 2007;3:211-21; Available from: http://msi-workgroups.sourceforge.net/index.html
71. Mendes P. Emerging bioinformatics for the metabolome. Brief Bioinform 2002;3:134-145
72. Nobeli I, Thorton JM. A bioinformatician's view of the metabolome. Bioessays 2006;28:534-545
73. Kanehisa M, Goto S KEGG. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30
74. Karp PD, Arnaud M, Collado-Vides J, et al. The E. coli EcoCyc database: no longer just a metabolic pathway database. ASM News 2004;70:25-30
75. Selkov E, Basmanova S, Gaasterland T, et al. The metabolic pathway collection from EMP: the enzymes and metabolic pathways database. Nucleic Acids Res 1996;24:26-28
76. Welcome to enzymes.info. Available from: http://www.brenda-enzymes.info/
77. PubChem. Available from: http://pubchem.ncbi.nlm.nih.gov/
78. Biological Magnetic Resonance Data Bank. Available from: http://www.bmrb.wisc.edu/metabolomics/
79. Human Metabolome Database. Available from: http://www.hmdb.ca/
80. Kopka J, Schauer N, Krueger S, et al. GMD@CSB.DB: the Golm metabolome database. Bioinformatics 2005;21:1635-1638
81. The Golm Metabolome Database. Available from: http://csbdb.mpimp-golm. mpg.de/csbdb/gmd/gmd.html
82. LIPID Metabolites And Pathways Strategy. Available from: www.lipidmaps.org/
83. Culf AS, Cuperlovic-Culf M, Ouellette RJ. Carbohydrate microarrays: survey of fabrication techniques. OMICS 2006;10:289-310
84. Cuperlovic-Culf M, Belacel N, Culf AS, Ouellette RJ. Microarray analysis of alternative splicing. OMICS 2006;10:344-357
85. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into relational therapeutics. Science 1999;286:487-491
86. Hieter P, Boguski M. Fuunctional genomics: it's all how you read it. Science 1997;278:601-602
87. Brent R. Genome biology. Cell 2000;10:169-183
88. Raamsdonk LM, Teusink B, Broadhurst D, et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature 2001;19:45-50
89. European Science Foundation Programme on Frontiers of Functional Genomics. Available from: http://www.functionalgenomics.org.uk/sections/ programme/index.htm
90. Sharaf MA, Illman DL, Kowalski BR. Chemometrics. John Wiley & Sons: New York; 1986
91. Boulesteix A, Strimmer K. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief Bioinform 2006;8:32-44
92. Cline MS, Smoot M, Cerami E, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Prot 2007;2:2366-2382
93. MetaNetter: Inferring networks from high resolution mass spectrometry. Available from: http://compbio.dcs.gla.ac.uk/fabien/abinitio/abinitio. html#download
94. Christian Klukas , Björn H. Junker and Falk Schreiber, "The VANTED software system for transcriptomics, proteomics and metabolomics analysis". J Pestic Sci 2006;31:289-292
95. PRIMe: Platform for RIKEN Metabolomics. Available from: http://prime.psc.riken.jp/
96. Fu J, Swertz MA, Keurentjes JBJ, et al. MetaNetwork: a computational protocol for the genetic study of metabolic networks. Nat Protocols 2007;2:685-694
97. Thimm O, Blasing O, Gibon Y, et al. MAPMAN: a user-driven tool to display genomics data sets onto diagrams of metabolic pathways and other biological processes. Plant J 2004;37:914-939
98. Karp PD, Paley S, Romero P. The pathway tools software. Bioinformatics 2002;18:225-232